评论
打印
In today's podcast, the China branch of British drugmaker GlaxoSmithKline has been fined a record 3 billion yuan by a court in the central province of Hunan.
在今天的播报中，湖南省法院对英国葛兰素史克中国分公司一案进行了裁决，并处罚金30亿元。
The Changsha Intermediate People's Court held a closed-door trial on September 19 on the case involving GlaxoSmithKline China which was accused of offering bribes. Five former GSK senior executives, including British national Mark Reilly, were sentenced to suspended prison terms of two to three years. Reilly, former head of GSK China, will be forced to leave the country. Reilly and the other executives admitted the charges during the investigation, and the court said that led to lighter punishments. The fine is the biggest that a Chinese court has ever handed a company, said Cheng Baoku, a law professor at Nankai University in Tianjin.
9月19日，长沙中级人民法院对英国葛兰素史克中国分公司涉嫌行贿一案进行了非公开审理。5名前葛兰素史克公司的高级管理人员，包括英国人马克锐，他被判处有期徒刑3年，缓刑四年的处罚。赖利，前葛兰素史克中国分公司总经理被驱逐出境。赖利以及其他几名管理人员在调查过程中对罪行供认不讳，法院称他们将受到较轻的处罚。天津南开大学法律教授程宝库称这样巨额的经济处罚是中国法院所从未遇到过的。
For Caixin Online, this is Diana Bates.
这是戴安娜·贝茨为您带来的财新报道。
译文属可可英语原创，未经允许，不得转载。
